UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:July 02,
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more BioLineRx Charts.
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more BioLineRx Charts.

Biolinerx Ltd. News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 6 May 2024 (1 week ago) • Edgar (US Regulatory)
BioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Wednesday 17 April 2024 (4 weeks ago) • PR Newswire (US)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Wednesday 28 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Friday 16 February 2024 (3 months ago) • Edgar (US Regulatory)
Form EFFECT - Notice of Effectiveness
Monday 8 January 2024 (4 months ago) • Edgar (US Regulatory)
Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 30 December 2023 (5 months ago) • Edgar (US Regulatory)
Form F-3 - Registration statement by foreign private issuers
Saturday 30 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Thursday 21 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 12 December 2023 (5 months ago) • Edgar (US Regulatory)
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 20 November 2023 (6 months ago) • Edgar (US Regulatory)
Monday’s Wall Street Highlights: GM, Microsoft, Citigroup, Amazon, and more
Monday 20 November 2023 (6 months ago) • IH Market News

More Biolinerx Ltd. News Articles